Methadone maintenance and cancer risk: An Israeli case registry study

Drug and Alcohol Dependence

Volumn 119, Issue 1-2, 2011, Pages 88-92

  Grinshpoon, Alexander ^a   Barchana, Micha ^b   Lipshitz, Irena ^b   Rosca, Paula ^b   Weizman, Abraham ^c   Ponizovsky, Alexander M ^b  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b MINISTRY OF HEALTH   (Israel)

^c GEHA MENTAL HEALTH CENTER   (Israel)

Author keywords

Cancer risk; Israel; Methadone maintenance treatment; Opioid dependence

Indexed keywords

METHADONE;

ADOLESCENT; ADULT; AGED; ARTICLE; BLADDER CANCER; BRAIN CANCER; BREAST CANCER; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; COHORT ANALYSIS; COLORECTAL CANCER; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; ETHNIC GROUP; ETHNICITY; FEMALE; HUMAN; ISRAEL; JEWISH; KIDNEY CANCER; LARYNX CANCER; LEUKEMIA; LIVER CANCER; LUNG CANCER; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; OPIATE ADDICTION; OVARY CANCER; PANCREAS CANCER; PRIORITY JOURNAL; PROSTATE CANCER; SEX DIFFERENCE; TESTIS CANCER; TREATMENT DURATION; UTERINE CERVIX CANCER;

ADOLESCENT; ADULT; AGED; ANALGESICS, OPIOID; COHORT STUDIES; DATABASES, FACTUAL; FEMALE; HUMANS; ISRAEL; MALE; METHADONE; MIDDLE AGED; NEOPLASMS; OPIATE SUBSTITUTION TREATMENT; REGISTRIES; RISK; RISK FACTORS; YOUNG ADULT;

EID: 80054983510     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2011.05.028     Document Type: Article

References (43)

1. Allardice G.M., Hole D.J., Brewster D.H., Boyd J., Goldberg D.J. Incidence of malignant neoplasms among HIV-infected persons in Scotland. Br. J. Cancer 2003, 89:505-507.
2. Amin J., Dore G.J., O'Connel D.L., Bartlett M., Tracey E., Kaldor J.M., Law M.G. Cancer incidence in people with hepatitis B or C infection: a large community-based linkage study. J. Hepatol. 2006, 45:197-203.
3. Bargagli A.M., Sperati A., Davoli M., Forastiere F., Perucci C.A. Mortality among problem drug users in Rome: an 18-year follow-up study, 1980-97. Addiction 2001, 96:1455-1463.
4. Bargagli A.M., Hickman M., Davoli M., Perucci C.A., Schifano P., Buster M., Brugal T., Vicente J. Drug-related mortality and its impact on adult mortality in eight European countries. Eur. J. Public Health 2006, 16:198-202.
5. Bjornaas M.A., Bekken A.S., Ojlert A., Haldorsen T., Jacobsen D., Rostrup M., Ekeberg O. A 20-year prospective study of mortality and causes of death among hospitalized opioid addicts in Oslo. BMC Psychiatry 2008, 13:8.
6. Boffetta P., Hashibe M., La Vecchia C., Zatonski W., Rehm J. The burden of cancer attributable to alcohol drinking. Int. J. Cancer 2006, 119:884-887.
7. Bromley E. Barriers to the appropriate clinical use of medications that improve the cognitive deficits of schizophrenia. Psychiatr. Serv. 2007, 58:475-481.
8. Brooner R.K., King V.L., Kidorf M., Schmidt C.W., Bigelow G.E. Psychiatric and substance use comorbidity among treatment-seeking opioid abusers. Arch. Gen. Psychiatry 1997, 54:71-80.
9. Brown S., Birtwistle J., Roe L., Thompson C. The unhealthy lifestyle of people with schizophrenia. Psychol. Med. 1999, 29:697-701.
10. Chapman C., Aboulafia D., Dezube B.J., Pantanowitz L. Colon adenocarcinoma in HIV infected patients. Infect. Agents Cancer 2009, 4:P32.
11. Chlebowski R.T., Blackburn G.L., Thomson C.A., Nixon D.W., Shapiro A., Hoy M.K., Goodman M.T., Giuliano A.E., Karanja N., McAndrew P., Hudis C., Butler J., Merkel D., Kristal A., Caan B., Michaelson R., Vinciguerra V., Del Prete S., Winkler M., Hall R., Simon M., Winters B.L., Elashoff R.M. Dietary fat reduction and breast cancer outcome: interim efficacy results from the Women's Intervention Nutrition Study. J. Natl. Cancer Inst. 2006, 98:1767-1776.
12. Degenhardt L., Bucello C., Mathers B., Briegleb C., Ali H., Hickman M., McLaren J. Mortality among regular or dependent users of heroin and other opioids: a systematic review and meta-analysis of cohort studies. Addiction 2011, 106:32-51.
13. Eland-Goossensen A., van de Goor I.A., Garretsen H.F. Heroin addicts in the community and in treatment compared for severity of problems and need for help. Subst. Use Misuse 1997, 32:1313-1330.
14. Felker B., Yazel J.J., Short D. Mortality and medical comorbidity among psychiatric patients: a review. Psychiatr. Serv. 1996, 47:1356-1363.
15. Ferreros I., Lumbreras B., Hurtado I., Pérez-Hoyos S., Hernández-Aguado I. The shifting pattern of cause-specific mortality in a cohort of human immunodeficiency virus-infected and non-infected injecting drug users. Addiction 2008, 103:651-659.
16. Frischer M., Goldberg D., Rahmanv M., Berney E.L. Mortality and survival among a cohort of drug injectors in Glasgow, 1982-1994. Addiction 1997, 92:419-427.
17. Gachupin-Garcia A., Selwyn P.A., Bunder N.S. Population-based study of malignancies and HIV infection among injecting drug users in a New York City methadone treatment program, 1985-1991. AIDS 1992, 6:843-848.
18. Gossop M., Stewart D., Treacy S., Marsden J. A prospective study of mortality among drug misusers during a 4-year period after seeking treatment. Addiction 2002, 97:39-47.
19. Grinshpoon A., Barchana M., Ponizovsky A., Lipshitz I., Nahon D., Tal O., Weizman A., Levav I. Cancer in schizophrenia: is the risk higher or lower?. Schizophr. Res. 2005, 73:333-341.
20. Herman A.I., Sofuoglu M. Cognitive effects of nicotine: genetic moderators. Addict. Biol. 2010, 15:250-265.
21. Hser Y.I., Hoffman V., Grella C.E., Anglin M.D. A 33-year follow-up of narcotics addicts. Arch. Gen. Psychiatry 2001, 58:503-508.
22. Isralowitz R., Reznik A., Spear S.E., Brecht M.L., Rawson R.A. Severity of heroin use in Israel: comparisons between native Israelis and former Soviet Union immigrants. Addiction 2007, 102:630-637.
23. Kerwin R. Connecting patient needs with treatment management. Acta Psychiatr. Scand. 2009, 438(Suppl.):33-39.
24. Koran L.M., Sox H.C., Marton K.I., Moltzen S., Sox C.H., Kraemer H.C., Imai K., Kelsey T.G., Rose T.G., Levin L.C. Medical evaluation of psychiatric patients. I. Results in a state mental health system. Arch. Gen. Psychiatry 1989, 46:733-740.
25. Levav I., Lipshitz I., Novikov I., Pugachova I., Kohn R., Barchana M., Ponizovsky A., Werner H. Cancer risk among parents and siblings of patients with schizophrenia. Br. J. Psychiatry 2007, 190:156-161.
26. Loebstein R., Mahagna R., Maor Y., Kurnik D., Elbaz E., Halkin H., Olchovsky D., Ezra D., Almog S. Hepatitis C, B, and human immunodeficiency virus infections in illicit drug users in Israel: prevalence and risk factors. Isr. Med. Assoc. J. 2008, 10:775-778.
27. McCabe M.P., Leas L. A qualitative study of primary health care access, barriers and satisfaction among people with mental illness. Psychol. Health Med. 2008, 13:303-331.
28. Modestin J., Matutat B., Würmle O. Antecedents of opioid dependence and personality disorder: attention-deficit/hyperactivity disorder and conduct disorder. Eur. Arch. Psychiatry Clin. Neurosci. 2001, 251:42-47.
29. Morabia A., Fabre J., Chee E., Zeger S., Orsat E., Robert A. Diet and opiate addiction: a quantitative assessment of the diet of non-institutionalized opiate addicts. Br. J. Addict. 1989, 84:173-180.
30. Neumark Y., Friedlander Y., Bar-Hamburger R. Family history and other characteristics of heroin-dependent Jewish males in Israel: results of a case-control study. Isr. Med. Assoc. J. 2002, 4:766-771.
31. No J.H., Kim M.K., Jeon Y.T., Kim Y.B., Song Y.S. Human papillomavirus vaccine: widening the scope for cancer prevention. Mol. Carcinog. 2011, 50:244-253.
32. Nolan L.J., Scagnelli L.M. Preference for sweet foods and higher body mass index in patients being treated in long-term methadone maintenance. Subst. Use Misuse 2007, 42:1555-1566.
33. Oyefeso A., Ghodse H., Clancy C., Corkery J., Goldfinch R. Drug abuse-related mortality: a study of teenage addicts over a 20-year period. Soc. Psychiatry Psychiatr. Epidemiol. 1999, 34:437-441.
34. Phelan M., Stradins L., Morrison S. Physical health of people with severe mental illness. BMJ 2001, 322:443-444.
35. Sanchez-Carbonell X., Seus L. Ten-year survival analysis of a cohort of heroin addicts in Catalonia: the EMETYST project. Addiction 2000, 95:941-948.
36. Sedjo R.L., Roe D.J., Abrahamsen M., Harris R.B., Craft N., Baldwin S., Giuliano A.R. Vitamin A, carotenoids, and risk of persistent oncogenic human papillomavirus infection. Cancer Epidemiol. Biomarkers Prev. 2002, 11:876-884.
37. Shiels M.S., Cole S.R., Mehta S.H., Kirk G.D. Lung cancer incidence and mortality among HIV-infected and HIV-uninfected injection drug users. J. Acquir. Immune Defic. Syndr. 2010, 55:510-515.
38. Strain E.C. Assessment and treatment of comorbid psychiatric disorders in opioid-dependent patients. Clin. J. Pain 2002, 18(Suppl. 4):S14-S27.
39. Tsai S.P., Wen C.P. A review of methodological issues of the standardized mortality ratio (SMR) in occupational cohort studies. Int. J. Epidemiol. 1986, 15:8-21.
40. Walboomers J.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer J.A., Shah K.V., Snijders P.J., Peto J., Meijer C.J., Muñoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 1999, 189:12-19.
41. Xue F., Willett W.C., Rosner B.A., Hankinson S.E., Michels K.B. Cigarette smoking and the incidence of breast cancer. Arch. Intern. Med. 2011, 171:125-133.
42. Zaccarelli M., Gattari P., Rezza G., Conti S., Spizzichino L., Vlahov D., Ippolito G., Lelli V., Valenzi C. Impact of HIV infection on non-AIDS mortality among Italian injecting drug users. AIDS 1994, 8:345-350.
43. Zador D., Lyons Wall P.M., Webster I. High sugar intake in a group of women on methadone maintenance in south western Sydney, Australia. Addiction 1996, 91:1053-1061.